The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 11,445 2,359,767 SH   SOLE   2,359,767 0 0
Advaxis Inc. COM NEW 007624208 1,611 225,000 SH   SOLE   225,000 0 0
Advaxis Inc. W EXP 07/15/201 007624117 446 112,500 SH   SOLE   112,500 0 0
Alcobra Ltd SHS M2239P109 2,532 1,205,498 SH   SOLE   1,205,498 0 0
Aldeyra Therapeutics Inc COM 01438T106 727 135,800 SH   SOLE   135,800 0 0
Ampio Pharmaceuticals Inc. COM 03209T109 2,492 2,738,322 SH   SOLE   2,738,322 0 0
Anavex Life Sciences Corp COM NEW 032797300 2,868 724,205 SH   SOLE   724,205 0 0
Bio Blast Pharma Ltd SHS M20156101 214 206,054 SH   SOLE   206,054 0 0
Caladrius Biosciences Inc COM NEW 128058203 157 55,579 SH   SOLE   55,579 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 21,665 2,563,925 SH   SOLE   2,563,925 0 0
Keryx Biopharmaceuticals Inc. COM 492515101 1,172 200,000 SH   SOLE   200,000 0 0
Newlink Genetics Corp COM 651511107 962 93,533 SH   SOLE   93,533 0 0
OHR Pharmaceutical Inc COM NEW 67778H200 306 204,137 SH   SOLE   204,137 0 0
Ritter Pharmaceuticals, Inc COM 767836109 2,581 952,434 SH   SOLE   952,434 0 0
Synthetic Biologics Inc. COM 87164U102 1,553 2,034,949 SH   SOLE   2,034,949 0 0
Vascular Biogenics LTD COM M96883109 4,174 860,605 SH   SOLE   860,605 0 0
Volition RX LTD COM 928661107 2,091 461,538 SH   SOLE   461,538 0 0